Gene · 54880
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm. | Cancers (Basel) | 2022 | 35884435 | PubTator, text mining | PubMed |
| Prognostic Factors of Pulmonary Metastasectomy for Soft Tissue Sarcomas Arising in the Trunk Wall and Extremities. | Cancers (Basel) | 2022 | 35884389 | PubTator, text mining | PubMed |
| The WHO 2021 Classification of Central Nervous System tumours: a practical update on what neurosurgeons need to know-a minireview. | Acta Neurochir (Wien) | 2022 | 35879477 | PubTator, text mining | PubMed |
| The fifth edition of the World Health Organization Classification of Tumors of the Central Nervous System: Implications for cancer registries. | Neuro Oncol | 2022 | 35877072 | PubTator, text mining | PubMed |
| Application of Multi-Omics Approach in Sarcomas: A Tool for Studying Mechanism, Biomarkers, and Therapeutic Targets. | Front Oncol | 2022 | 35875106 | PubTator, text mining | PubMed |
| Integrative analysis of drug response and clinical outcome in acute myeloid leukemia. | Cancer Cell | 2022 | 35868306 | PubTator, text mining | PubMed |
| Treatment of blast phase chronic myeloid leukaemia: A rare and challenging entity. | Br J Haematol | 2022 | 35866251 | PubTator, text mining | PubMed |
| Taking the EZ way: Targeting enhancer of zeste homolog 2 in B-cell lymphomas. | Blood Rev | 2022 | 35851487 | PubTator, text mining | PubMed |
| The spectrum of genetic mutations in myelodysplastic syndrome: Should we update prognostication? | EJHaem | 2022 | 35846202 | PubTator, text mining | PubMed |
| Multi-Omics Analysis and Machine Learning Prediction Model for Pregnancy Outcomes After Intracytoplasmic Sperm Injection-in vitro Fertilization. | Front Public Health | 2022 | 35844885 | PubTator, text mining | PubMed |
| Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia. | Blood Cancer Discov | 2022 | 35839275 | PubTator, text mining | PubMed |
| Paediatric BCOR-associated sarcomas with a novel long spliced internal tandem duplication of BCOR exon 15. | J Pathol Clin Res | 2022 | 35836306 | PubTator, text mining | PubMed |
| A Novel Prognostic Scoring Model for Myelodysplastic Syndrome Patients With SF3B1 Mutation. | Front Oncol | 2022 | 35832562 | PubTator, text mining | PubMed |
| Massively targeted evaluation of therapeutic CRISPR off-targets in cells. | Nat Commun | 2022 | 35831290 | PubTator, text mining | PubMed |
| Ultra-sensitive monitoring of leukemia patients using superRCA mutation detection assays. | Nat Commun | 2022 | 35821208 | PubTator, text mining | PubMed |
| Case Report: An Adolescent Soft Tissue Sarcoma With YWHAE-NUTM2B Fusion Is Effectively Treated With Combined Therapy of Epirubicin and Anlotinib. | Front Oncol | 2022 | 35814390 | PubTator, text mining | PubMed |
| Genetic variation associated with condensate dysregulation in disease. | Dev Cell | 2022 | 35809564 | PubTator, text mining | PubMed |
| CNS tumor with BCOR internal tandem duplication: Clinicopathologic, molecular characteristics and prognosis factors. | Pathol Res Pract | 2022 | 35809497 | PubTator, text mining | PubMed |
| Screening a Targeted Panel of Genes by Next-Generation Sequencing Improves Risk Stratification in Real World Patients with Acute Myeloid Leukemia. | Cancers (Basel) | 2022 | 35805006 | PubTator, text mining | PubMed |
| Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms. | Blood Cancer J | 2022 | 35803921 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54880/papers?page=51